Skip to content

Helping You Burn Fat Naturally Results from a Human Trial of Zeroharm fat burner Tablets

clinical study to evaluate the Efficacy of Fat Burner in the management of obesity - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092541
Enrollment
50
Registered
2025-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E663- Overweight

Interventions

None listed

Sponsors

Zeroharm Science Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: subjects having BMI more than 30 kg/m2 and lower than 40 kg/m2 Subjects not suffering from any significant illness (medical or surgical) Subjects not not currently taking weight loss medications or supplements

Exclusion criteria

Exclusion criteria: Subjects below 18 years or above 60 years of age Patient having very high level of dyslipidaemia Individuals with a history of cardiovascular disease, liver or kidney dysfunction, or those taking medications affecting weight.

Design outcomes

Primary

MeasureTime frame
Change in body weight and fat mass. Result will be assessed on the basis of body weight, BMI, Body circumference measurements of certain regions.Timepoint: 12 weeks

Secondary

MeasureTime frame
1. Changes in metabolic markers (blood glucose, lipid profile, inflammatory markers) 2.Assessment of appetite and satiety (using validated questionnaires). 3. Evaluation of side effects and overall safety through regular monitoring.Timepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Pranabjyoti Baishya

Government Ayurvedic College, Jalukbari, Guwahati -14 , Assam

drpjbaishya1967@gmail.com8822376327

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026